|
Herbal medicine | Suppressive effects on carcinogenesis and cancer metastasis | References |
|
For breast cancer |
Vitamin A (fenretinide) | 200 mg/day significantly reduces the recurrence of local breast cancer in premenopausal women | [4] |
Vitamin E | Leads to malabsorption or maldigestion in cancer patients; balanced and healthy diet | [5, 6] |
Isoflavone | To reduce risk of breast cancer | [10] |
Isoflavones genistein and daidzein | To confer weak estrogenic effects | [11] |
Alkaloids | Inhibition of cancer cell growth | [13, 14] |
Coumarins | Inhibition of cancer cell growth | [15, 16] |
Flavonoids and polyphenols | Antiproliferation | [17, 18] |
Terpenoids | MCF-7 cell apoptosis | [19] |
Quinone | To induce G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells | [20] |
Artemisunate | Decrease the proliferation of human breast cancer cells from expressing a high ERα : ERβ ratio | [21] |
|
For prostate cancer |
Vitamins A-D and retinoid | Maintain homeostasis and prevent various metabolic disorders | [23] |
Vitamin E | Reduce the risk of lethal or advanced prostate cancer relative to nonusers | [30] |
Epigallocatechin-3-gallate (EGCG) | Arrest LNCaP and DU145 prostate cancer cells at the G0-G1 phase of the cell cycle | [34] |
Inhibit metalloproteinase in vitro | [35] |
Soy isoflavones | Inhibit 5α-reductase activity | [37] |
Chemopreventive activities | [22] |
Scutellaria baicalensis (baicalin) | Inhibit enzymatic synthesis of eicosanoids | [38] |
Baicalein | Impair the proliferation of androgen-independent PC-3 and DU145 prostate cancer cells in culture | [39] |
Induces cell-cycle arrest at the G0-G1 phase | [39] |
Induces apoptosis of prostate cancer cells at concentrations achievable in humans | [40] |
Suppresses the expression of specific androgen receptor in prostate cancer | [40] |
Lycopenes | Decreases prostate cancer risk | [41] |
Diminishes oxidative damage in lymphocytes | [42] |
Significantly decreases levels of PSA and less oxidative damage | [42] |
PC-SPES | Decreases serum testosterone concentrations (); decreases serum concentrations of prostate-specific antigen | [43] |
Antitumor efficacy against cancer cell lines | [44] |
Wedelia chinensis (Asteraceae) | Inhibits the androgen receptor (AR) signaling pathway | [47] |
|
For lung cancer |
Platycodon grandiflorum (Campanulaceae) | Anticancer effect in lung cancer patients | [49–51] |
Morus alba (Moraceae) | Anticancer effect in lung cancer patients |
Prunus armeniaca (Rosaceae) | Anticancer effect in lung cancer patients |
Rhus verniciflua (Anacardiaceae) | Anticancer effect in lung cancer patients |
Perilla frutescens (Labiatae) | Anticancer effect in lung cancer patients |
Stemona japonica (Stemonaceae) | Anticancer effect in lung cancer patients |
Tussilago farfara (Compositae) | Anticancer effect in lung cancer patients |
Draba nemorosa (Brassicaceae) | Anticancer effect in lung cancer patients |
|
For liver fibrosis and cancer |
Inchin-ko-to (TJ-135) | Preventive effect on liver fibrosis | [53] |
Yi Guan Jian (YGJ) | [53] |
Yi Guan Jian (YGJ) | [54] |
Fufang-Liu-Yue-Qing | [55] |
Danggui Buxue Tang (DBT) | [56] |
Salvianolic acid B | | |
Curcumin | Suppressive effect on hepatic fibrogenesis and carcinogenesis | [57] |
Oxymatrine | | |
Compound 861 | Suppressive effect on hepatic fibrogenesis | [58, 59] |
Sho saiko-to (TJ-9) | Reduces/limits the progression of hepatocellular carcinoma | [60] |
|
For pancreatic cancer |
GDC-0449, IPI-926, XL-139 and PF-04449913 | SMO antagonists; deregulation of sonic hedgehog homology (SHH) | [61] |
Cyclopamine | Inhibit SHH signaling by directly binding to the 7-helix bundle of the SMO protein; arrest the growth of pancreatic tumors | [62] |
Weakens the recruitment of BMPCs into cancer cells and reduces the formation of tumor vasculature | [63] |
The cancerous vascular system becomes unstable after treatment with cyclopamine due to the expression of angiopoietin-1 | [63] |
|